Back to search

Article

Terazosin drives sex-dependent adrenergic–bioenergetic reprogramming to restore network function in Alzheimer’s disease

2026-04-06

Abstract excerpt

<h4>ABSTRACT</h4> Alzheimer’s disease (AD) has long been defined by amyloid-β plaques and hyperphosphorylated tau, yet disease-modifying therapies remain critically limited. Growing evidence reframes AD as a system-level failure driven by early dysregulation of synaptic, metabolic, and neuroimmune pathways, preceding overt protein aggregation and originating in selectively vulnerable circuits, including the locus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
829c8bf4-793e-502b-9002-841d50704b1b
DOI
10.64898/2026.04.02.716175
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Terazosin drives sex-dependent adrenergic–bioenergetic reprogramming to restore network function in Alzheimer’s diseaseDOI 10.64898/2026.04.02.716175
Select a neighboring publication to make it the new centre.